New Formulations, New Sensations

Formulation Strategies For Minor Cannabinoids (+ Products We Love) Author: Nicole Brown (OBX Chief Revenue Officer) Jan 4, 2021 – 8 min read “Hey hey, are you ready for ? (New formulations, new formulations) Right now Gonna take you over (New formulations,...

A Call to Arms for Open Innovation

Author: Dave Neundorfer Dec 1, 2020 – 5 min read Last month, I shared with you a guide to quality control in CBD 3.0, where we discussed the technological advancements and testing methods necessary to ensure the integrity and consistency of your supply chain and...

Your Guide To Quality Control In CBD 3.0

Author: Dave Neundorfer Nov 3, 2020 – 8 min read Over the past few months, we’ve shared our perspective on what the cannabinoid industry needs to graduate from a nascent, $1B industry into the mainstream, cross-category, $20B+ powerhouse that analysts have...

Are Your Products Ready For CBD 3.0?

Author: Nicole Brown, CCO Over the past few months, we’ve shared our future perspective on the industry as we climb to CBD 3.0 — the need for research, the therapeutic promise of minor cannabinoids, the flight to quality that brands and the “buyers of tomorrow”...

The Regulatory Barbell Problem

Author: Dave Neundorfer, CEO As everyone knows, the FDA is yet to create a clear legal framework for the use of cannabinoids in dietary supplements, food and beverage products. This has created a regulatory barbell effect in the market, with the “Wild West” on one...
Our team is your team and we want to share our knowledge with you.

Our team is your team and we want to share our knowledge with you.

 

Join over 2000 of your industry peers following along.

 

 

Subscribe to receive the latest industry updates, news from OBX, and special offers.

You have Successfully Subscribed!